These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Neuronal damage induced by beta-N-oxalylamino-L-alanine, in the rat hippocampus, can be prevented by a non-NMDA antagonist, 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline. Willis CL; Meldrum BS; Nunn PB; Anderton BH; Leigh PN Brain Res; 1993 Nov; 627(1):55-62. PubMed ID: 7507397 [TBL] [Abstract][Full Text] [Related]
6. Postischemic blockade of AMPA but not NMDA receptors mitigates neuronal damage in the rat brain following transient severe cerebral ischemia. Nellgård B; Wieloch T J Cereb Blood Flow Metab; 1992 Jan; 12(1):2-11. PubMed ID: 1345757 [TBL] [Abstract][Full Text] [Related]
7. AMPA, but not NMDA, receptor antagonism is neuroprotective in gerbil global ischaemia, even when delayed 24 h. Sheardown MJ; Suzdak PD; Nordholm L Eur J Pharmacol; 1993 Jun; 236(3):347-53. PubMed ID: 7689464 [TBL] [Abstract][Full Text] [Related]
8. Dizocilpine maleate, MK-801, but not 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline, NBQX, prevents transneuronal degeneration of nigral neurons after neurotoxic striatal-pallidal lesion. DeGiorgio LA; DeGiorgio N; Volpe BT Neuroscience; 1999 Apr; 90(1):79-85. PubMed ID: 10188935 [TBL] [Abstract][Full Text] [Related]
9. Ability of NMDA and non-NMDA receptor antagonists to inhibit cerebral ischemic damage in aged rats. Suzuki Y; Takagi Y; Nakamura R; Hashimoto K; Umemura K Brain Res; 2003 Feb; 964(1):116-20. PubMed ID: 12573519 [TBL] [Abstract][Full Text] [Related]
10. Are NMDA or AMPA/kainate receptor antagonists more efficacious in the delayed treatment of excitotoxic neuronal injury? Prehn JH; Lippert K; Krieglstein J Eur J Pharmacol; 1995 Jan; 292(2):179-89. PubMed ID: 7720791 [TBL] [Abstract][Full Text] [Related]
11. In vivo and in vitro evaluation of AMPA receptor antagonists in rat hippocampal neurones and cultured mouse cortical neurones. Mathiesen C; Varming T; Jensen LH Eur J Pharmacol; 1998 Jul; 353(2-3):159-67. PubMed ID: 9726646 [TBL] [Abstract][Full Text] [Related]
13. N-methyl-D-aspartate receptor blockade after status epilepticus protects against limbic brain damage but not against epilepsy in the kainate model of temporal lobe epilepsy. Brandt C; Potschka H; Löscher W; Ebert U Neuroscience; 2003; 118(3):727-40. PubMed ID: 12710980 [TBL] [Abstract][Full Text] [Related]
15. Cerebral protection by AMPA- and NMDA-receptor antagonists administered after severe insulin-induced hypoglycemia. Nellgård B; Wieloch T Exp Brain Res; 1992; 92(2):259-66. PubMed ID: 1362958 [TBL] [Abstract][Full Text] [Related]
16. Stretch-induced injury in organotypic hippocampal slice cultures reproduces in vivo post-traumatic neurodegeneration: role of glutamate receptors and voltage-dependent calcium channels. Cater HL; Gitterman D; Davis SM; Benham CD; Morrison B; Sundstrom LE J Neurochem; 2007 Apr; 101(2):434-47. PubMed ID: 17250683 [TBL] [Abstract][Full Text] [Related]
17. Calcium movements in traumatic brain injury: the role of glutamate receptor-operated ion channels. Nilsson P; Laursen H; Hillered L; Hansen AJ J Cereb Blood Flow Metab; 1996 Mar; 16(2):262-70. PubMed ID: 8594058 [TBL] [Abstract][Full Text] [Related]
18. NBQX, a competitive non-NMDA receptor antagonist, reduces degeneration due to focal spinal cord ischemia. von Euler M; Seiger A; Holmberg L; Sundström E Exp Neurol; 1994 Sep; 129(1):163-8. PubMed ID: 7925838 [TBL] [Abstract][Full Text] [Related]
19. NMDA-receptor blockers but not NBQX, an AMPA-receptor antagonist, inhibit spreading depression in the rat brain. Nellgård B; Wieloch T Acta Physiol Scand; 1992 Dec; 146(4):497-503. PubMed ID: 1283483 [TBL] [Abstract][Full Text] [Related]
20. Over-additive protective effect of dizocilpine and NBQX against neuronal damage. Lippert K; Welsch M; Krieglstein J Eur J Pharmacol; 1994 Mar; 253(3):207-13. PubMed ID: 7911083 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]